BRIEF-Ariad announces submission of marketing authorization application for Brigatinib

* Ariad announces submission of marketing authorization application for Brigatinib to the European Medicines Agency
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.